Low rejection rate with high-dose ATG bolus therapy in simultaneous pancreas and kidney transplantation
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
11377538
DOI
10.1016/s0041-1345(01)02000-0
PII: S0041134501020000
Knihovny.cz E-resources
- MeSH
- Antilymphocyte Serum administration & dosage therapeutic use MeSH
- Time Factors MeSH
- Kidney Failure, Chronic surgery MeSH
- Diabetes Mellitus, Type 1 surgery MeSH
- Diabetic Nephropathies surgery MeSH
- Adult MeSH
- Injections, Intravenous MeSH
- Humans MeSH
- Survival Rate MeSH
- Lymphocyte Count MeSH
- Platelet Count MeSH
- Disease-Free Survival MeSH
- Graft Survival MeSH
- Graft Rejection epidemiology prevention & control MeSH
- Retrospective Studies MeSH
- Kidney Transplantation immunology methods mortality MeSH
- Pancreas Transplantation immunology methods mortality MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antilymphocyte Serum MeSH
References provided by Crossref.org
Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset